Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Latest filing published 03 Sept 2026 for Entrada Therapeutics, Inc., €11k.
Filing timeline
BuySaleKory James Wentworth
Insider track record
Disclosed buys
0
Disclosed sells
22
Signal history
Kory James Wentworth: trading record in brief
Kory James Wentworth (finance chief) discloses dealings in 2 companies, chiefly Entrada Therapeutics, Inc. and bluebird bio, Inc. The record holds 51 filings, for trades running from 2 January 2018 to 2 September 2026.
Every open-market trade on record is a sale: 22 sales worth €576k. The rest of the record consists of 15 share grants and 14 option exercises. In 2026 alone, the filings show no purchases and 3 sales.
The latest filing, published on 3 September 2026, reports a share grant of €11k in Entrada Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kory James Wentworth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations51 total
1,733 shares@ US$7.14390.0048% mcap1.9% of flowCommon StockSEC:0001725663-26-000007:0
2,500 shares@ US$12.950.011% mcap5.1% of flowCommon StockSEC:0001725663-26-000005:0
5,089 shares@ US$13.001110.5% of flowCommon StockSEC:0001725663-26-000003:0
7,988 shares@ US$12.254915.3% of flowCommon StockSEC:0001725663-26-000002:0
44,600 shares0Common StockSEC:0001725663-26-000001:0
8,910 shares@ US$9.981114.0% of flowCommon StockSEC:0001725663-25-000004:0
1,734 shares@ US$5.43021.5% of flowCommon StockSEC:0001725663-25-000003:0
11,134 shares@ US$2.103.9% of flowCommon StockSEC:0001689375-25-000019:0
1,784 shares@ US$10.673.2% of flowCommon StockSEC:0001689375-25-000016:0
42,400 shares0Common StockSEC:0001689375-25-000014:0
1,000 shares@ US$2.100.4% of flowCommon StockSEC:0001689375-24-000068:0
6,000 shares@ US$2.102.1% of flowCommon StockSEC:0001689375-24-000065:0
3,195 shares@ US$14.9717.9% of flowCommon StockSEC:0001689375-24-000055:0
462 shares@ US$15.76111.2% of flowCommon StockSEC:0001689375-24-000049:0
1,758 shares@ US$14.954.4% of flowCommon StockSEC:0001689375-24-000039:0
9,000 shares@ US$2.103.2% of flowCommon StockSEC:0001689375-24-000017:0
4,086 shares@ US$12.30678.4% of flowCommon StockSEC:0001689375-24-000008:0
30,900 shares0Common StockSEC:0001689375-24-000005:0
2,200 shares@ US$2.100.8% of flowCommon StockSEC:0001689375-23-000077:0
14,200 shares0Common StockSEC:0001689375-23-000064:0
6,116 shares@ US$2.102.1% of flowCommon StockSEC:0001689375-23-000048:0
8,790 shares@ US$2.103.1% of flowCommon StockSEC:0001689375-23-000045:0
17,500 shares@ US$2.106.1% of flowCommon StockSEC:0001689375-23-000044:0
14,200 shares0Common StockSEC:0001689375-23-000028:0
28,400 shares0Common StockSEC:0001689375-23-000015:0
25 of 51 declarations
